Dandelion Health AI

What Dandelion Health AI does

Dandelion Health AI (legal entity Dandelion Health Inc., New York) is a clinical data and AI platform founded in 2020 by Elliott Green (CEO), Niyum Gandhi (Board Chair), Ziad Obermeyer (CSO), and Sendhil Mullainathan (Scientific Advisor). The company's core offering is a multimodal Precision Medicine Platform that aggregates structured EHR data with unstructured clinical content (imaging, ECG waveforms, clinical notes) from a consortium of 73 hospitals covering 15M+ patients with longitudinal records dating to 2016, totaling 8+ petabytes. On top of this platform, Dandelion operates the Clinical AI Marketplace (launched September 2024), the GLP-1 Data Library (210K+ GLP-1 users, 300K+ matched controls, launched May 2024), the Cardiometabolic Data Library, the AHA AI Assessment Lab co-branded with the American Heart Association, and a free AI Algorithm Validation Service funded by The SCAN Foundation.

The underlying technology combines NLP/LLM extraction of clinical notes, computer vision over echocardiograms and other imaging (including AI-generated cardiac measurements delivering up to 30x more data points per patient via the InVision partnership), and predictive analytics such as ECG-based MACE risk models. The business model is enterprise data licensing and platform subscription targeting two primary segments: life-sciences companies (early clinical research through indication expansion) and AI developers (training, validation, regulatory approval, and commercialization support). Pricing is quote-based with no public tiers, and monetization occurs through platform subscriptions, data-library licensing, and algorithm deployment fees. The company raised a $14M Series A in May 2026 led by Healthier Capital, is actively expanding its health-system consortium (latest addition: Montefiore Einstein, October 2025), and reports a customer-outcomes case showing up to $84M in projected cost savings and 11 months of timeline compression in a trial emulation with a top-10 pharmaceutical company.

Name

Dandelion Health AI

Legal name

Dandelion Health Inc.

Website

https://dandelionhealth.ai

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Dandelion Health AI operates a multimodal clinical data platform spanning 73 hospitals and 15M+ patients, offering AI-powered data libraries and a Clinical AI Marketplace to pharmaceutical companies and clinical AI developers for drug development and algorithm validation.

Ownership category

akta.pro rank

Product category

Healthcare Real-World Data and Clinical AI Platform

NAICS

Software Publishers (5132), Scientific Research and Development Services (5417)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

akta.pro secondary industries

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Medical Imaging AI (HDAAAEAH)

Keywords

• Real-world data platform
• Clinical AI marketplace
• Multimodal healthcare data
• AI algorithm validation
• Precision medicine analytics

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Life Sciences Data Platform Access: Providing pharmaceutical and life sciences companies access to multimodal RWD platform for clinical research, drug development, and trial emulation purposes. Revenue generated through platform subscription and data licensing agreements.
2. Clinical AI Marketplace: Platform hosting validated AI algorithms from developers, enabling life sciences companies to access AI-powered data extraction services. Revenue from algorithm deployment and data processing fees.
3. Data Library Licensing: Specialized data libraries (GLP-1 Data Library, Cardiometabolic Data Library) licensed to researchers and pharmaceutical companies for specific therapeutic area studies
4. AI Algorithm Validation Services: Free validation service for AI developers (supported by The SCAN Foundation), with potential monetization through premium validation and commercialization support services

Distribution channels2 records

Marketing channels5 records

Core offering

Dandelion Health AI provides a multimodal Precision Medicine Platform and Clinical AI Marketplace that aggregates structured EHR data, clinical notes, imaging, and waveforms from 73+ hospitals covering 15+ million patients (8+ petabytes), and licenses this regulatory-grade real-world data along with vetted third-party AI algorithms to life sciences companies and AI developers for drug development, trial emulation, and clinical AI validation.

Product overview

Dandelion Health operates a platform-plus-data model with its core Precision Medicine Platform as the foundational infrastructure. The platform aggregates multimodal patient data (structured EHR, imaging, waveforms, clinical notes) from a consortium of 73+ hospitals covering 15+ million patients. Built on this platform are specialized Data Libraries (GLP-1 Data Library, Cardiometabolic Data Library), the Clinical AI Marketplace for algorithm access and validation, and the AHA AI Assessment Lab for independent algorithm testing. The ecosystem enables life sciences companies and AI developers to accelerate drug development, clinical trials, and precision medicine research.

Differentiator

Problem solved

Functional benefit

Brands

• GLP-1 Data Library: The first truly multimodal real-world clinical dataset purpose-built to capture the underlying biology of cardiometabolic diseases, including the role of GLP-1s in treatment. Contains 210K+ GLP-1 users and 300K+ matched controls with longitudinal data from 2016.
• Clinical AI Marketplace
• Precision Medicine Platform
• AHA AI Assessment Lab, powered by Dandelion Health

Products and services

• Dandelion Precision Medicine Platform (Dandelion Data)

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered core.

• Montefiore EinsteincoreTechnology or Integration · 17 October 2025Academic medical center joining Dandelion's consortium to accelerate AI-driven drug development and new clinical care solutions. Expanding the consortium's data coverage.
• PheironcoreTechnology or Integration · 18 September 2024AI algorithm developer whose ECG-biomarker algorithm predicting MACE risk was validated and deployed on Dandelion's Clinical AI Marketplace for GLP-1 cardioprotective benefits research.
• InVision Medical TechnologycoreTechnology or Integration · 30 April 2024Partnership to provide life sciences companies with AI-generated cardiac measurements from echocardiogram data. AI technology generates up to 30x more data points per patient by analyzing raw imaging data combined with longitudinal patient records. Collaboration aims to power research across heart failure, ASCVD, cardiomyopathies, cardio-oncology, and cardiometabolic landscape.
• The SCAN FoundationcoreStrategic or Co-development Partner · 22 February 2024Partnership to advance algorithmic equity for underrepresented patient populations through free algorithm audit service. Funded development of validation framework evaluating AI models against social determinants of health (SDoH) and demographic measures.
• American Heart Association (AHA AI Assessment Lab)coreStrategic or Co-development Partner · 1 January 2024Joint initiative providing independent, scientifically rigorous assessments of cardiology and stroke algorithms. Enables algorithms to compete on quality, reduces transaction costs for hospitals and developers, and accelerates patient access to validated AI innovation.
• Sharp HealthCare (California)coreTechnology or Integration · 1 January 2020Large regional health system partner contributing patient data to Dandelion's consortium. Part of diverse consortium of healthcare systems providing representative patient populations across different geographic and socioeconomic regions.
• Sanford Health (South Dakota)coreTechnology or Integration · 1 January 2020Large regional health system partner contributing patient data to Dandelion's consortium. Represents rural patient populations helping ensure algorithms are representative of diverse demographics.
• Texas Health ResourcescoreTechnology or Integration · 1 January 2020Large regional health system partner contributing patient data to Dandelion's consortium. Represents diverse Texas patient populations in the consortium.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Tempus AI: Tempus AI is a precision medicine company building one of the world's largest multimodal clinical and molecular data libraries, paired with AI models, to serve life sciences R&D and clinical care. Direct overlap with Dandelion in multimodal RWD + AI for pharma use cases, though Tempus is much larger and oncology-heavy.
• Flatiron Health: Flatiron Health (acquired by Roche) pioneered oncology-specific real-world data and EHR-derived analytics for pharma research and clinical decision support. Direct peer in the RWD-for-life-sciences model, with deeper oncology penetration and Roche backing.
• Komodo Health: Komodo Health operates a large healthcare intelligence platform combining claims, EHR, and other data sources to map patient journeys for life sciences and healthcare stakeholders. Closely comparable in serving pharma with linked patient-level data, though Komodo leads on claims depth while Dandelion leads on multimodal clinical depth.
• ConcertAI: ConcertAI is a healthcare AI and real-world evidence company focused on oncology and clinical trial optimization, serving biopharma with curated RWD and AI tools. Overlaps with Dandelion's life sciences RWD business model; narrower therapeutic focus (primarily oncology).
• Aetion: Aetion provides a real-world evidence analytics platform purpose-built for regulatory-grade outcomes research, used by biopharma and regulators. Direct peer in RWE analytics for pharma submissions, though Dandelion differentiates on multimodal clinical depth while Aetion leads on regulatory science software.

Broad incumbents

• Datavant: Datavant is a health data connectivity and de-identification platform that enables linking of patient records across data sources for life sciences and healthcare. Adjacent to Dandelion's data licensing model; Datavant focuses on connectivity infrastructure while Dandelion focuses on curated multimodal analytics.
• IQVIA: IQVIA is the largest contract research organization and healthcare data company globally, combining clinical research services with extensive RWD assets for life sciences. Comparable at the customer-segment level (pharma) but vastly larger and broader; Dandelion's multimodal differentiation is its main moat.
• Health Catalyst: Health Catalyst is a healthcare data and analytics platform serving health systems with population health and clinical analytics, with growing life sciences offerings. Comparable as a healthcare data analytics player, though primarily serving provider systems rather than life sciences directly.
• Veradigm (formerly Allscripts): Veradigm is an EHR and healthcare data analytics provider that sells de-identified clinical data from its installed base to life sciences for research. Comparable in EHR-derived RWD for pharma, though Veradigm is primarily an EHR vendor rather than a dedicated life sciences data platform.

Emerging players

• Verily Life Sciences: Verily (Alphabet) operates longitudinal clinical data platforms and real-world evidence initiatives, including partnerships with health systems for multi-modal data and life sciences collaborations. Comparable in combining multimodal clinical data with AI for pharma; differs in scale (Alphabet-backed) and primary focus on cohort-building and clinical operations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/dandelion-health-ai
• Xx.com/Dandelion_AI4H

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles23 records

Funding overview

Funding rounds4 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dandelion Health AI